Abstracts tagged "PROMIS and rheumatoid arthritis (RA)"

Abstract Number: 2474 • 2018 ACR/ARHP Annual Meeting
Development of a Crosswalk for FACIT-10 (Psychometric Work)
Clifton O. Bingham III¹, Susan J. Bartlett^2,3, David Cella⁴, Amy M. DeLozier⁵, Luna Sun⁵, Amanda Quebe⁵, Susan Otawa⁵ and Carol L. Gaich⁵, ¹Johns Hopkins University, Baltimore, PA, ²Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ³Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, ⁴Northwestern University, Chicago, IL, ⁵Eli Lilly and Company, Indianapolis, IN
Background/Purpose: Fatigue in patients with rheumatoid arthritis (RA) may be measured with the 13-item Functional Assessment of Chronic Illness Therapy-Fatigue instrument (FACIT-F). The Patient-Reported Outcomes…
Abstract Number: 2248 • 2017 ACR/ARHP Annual Meeting
Function, Pain, Fatigue, and Participation Are the Primary Contributors to the Patient Global Assessment in Rheumatoid Arthritis
Ethan Craig¹, Susan J. Bartlett², Jamie Perin³, Scott Zeger³ and Clifton O. Bingham III¹, ¹Rheumatology, Johns Hopkins University, Baltimore, MD, ²Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, ³Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD
Background/Purpose: The patient global assessment (PGA) is widely used in disease activity scores for RA, including the CDAI, SDAI, and DAS28. While pain has been…
Abstract Number: 539 • 2016 ACR/ARHP Annual Meeting
Promis Short Forms Are Relevant to People Living with RA: Results of Cognitive Debriefing Interviews
Anna Kristina Gutierrez¹, Susan J. Bartlett^1,2, Alessandra Butanis³, Vivian P. Bykerk⁴, Jeffrey R. Curtis⁵, Amye L. Leong⁶, Anne Lyddiatt⁷ and Clifton Bingham III⁸, ¹Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, ³Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Divison of Rheumatology, Hospital for Special Surgery, New York, NY, ⁵Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁶Strategic Relations, Bone & Joint Decade, Santa Barbara, CA, ⁷Musculoskeletal Group, Cochrane Collaboration, Hamilton, ON, Canada, ⁸Johns Hopkins University, Baltimore, MD
Background/Purpose: PROMIS® measures were developed to assess physical, mental, and social health across chronic diseases and include brief short forms (SFs; 4-8 items) to assess…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].